课题基金 / 基金详情

A new therapeutic agent for the treatment and prevention of endoleaks after endovascular aneurysm repair

A new therapeutic agent for the treatment and prevention of endoleaks after endovascular aneurysm repair
一种治疗和预防血管内动脉瘤修复术后内漏的新治疗剂
批准号:
205369
负责人:
Lerouge Sophie
金额:
$11.29万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2010
资助国家:
加拿大
项目状态:
已结题
起止时间:
2010-03-01 至 2011-03-01

项目摘要

项目成果

Lerouge Sophie的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Aortic aneurysms (AA) are dilatations of a large vessel in the abdomen, present in approximately 5% of the population. They are usually caused by atherosclerosis. This dilatation can lead to aneurysm rupture which is a life-threatening event. The classica
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Injectable bioactive hydrogel for the regeneration of intervertebral disc
Injectable thermosensitive hydrogel as delivery vehicle of lymphocytes for cancer immunotherapy
Innovative vascular implants based on electrospinning and bioactive coatings
海外基金